These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 11156753)

  • 21. Treatment of agitation and aggression in bipolar mania: efficacy of quetiapine.
    Buckley PF; Paulsson B; Brecher M
    J Affect Disord; 2007; 100 Suppl 1():S33-43. PubMed ID: 17376537
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Divalproex sodium for the treatment of behavioural problems associated with dementia in the elderly.
    Porsteinsson AP
    Drugs Aging; 2006; 23(11):877-86. PubMed ID: 17109566
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A randomized, double-blind, placebo-controlled pilot trial of safety and tolerability of two doses of divalproex sodium in outpatients with probable Alzheimer's disease.
    Profenno LA; Jakimovich L; Holt CJ; Porsteinsson A; Tariot PN
    Curr Alzheimer Res; 2005 Dec; 2(5):553-8. PubMed ID: 16375658
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Divalproex extended-release in adolescent migraine prophylaxis: results of a randomized, double-blind, placebo-controlled study.
    Apostol G; Cady RK; Laforet GA; Robieson WZ; Olson E; Abi-Saab WM; Saltarelli M
    Headache; 2008 Jul; 48(7):1012-25. PubMed ID: 18705027
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effect of oxcarbazepine in the treatment of agitation and aggression in severe dementia.
    Sommer OH; Aga O; Cvancarova M; Olsen IC; Selbaek G; Engedal K
    Dement Geriatr Cogn Disord; 2009; 27(2):155-63. PubMed ID: 19182483
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Maintenance treatment for patients with bipolar I disorder: results from a north american study of quetiapine in combination with lithium or divalproex (trial 127).
    Suppes T; Vieta E; Liu S; Brecher M; Paulsson B;
    Am J Psychiatry; 2009 Apr; 166(4):476-88. PubMed ID: 19289454
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Safety and efficacy of switching psychiatric patients from a delayed-release to an extended-release formulation of divalproex sodium.
    Horne RL; Cunanan C
    J Clin Psychopharmacol; 2003 Apr; 23(2):176-81. PubMed ID: 12640219
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effect of Dextromethorphan-Quinidine on Agitation in Patients With Alzheimer Disease Dementia: A Randomized Clinical Trial.
    Cummings JL; Lyketsos CG; Peskind ER; Porsteinsson AP; Mintzer JE; Scharre DW; De La Gandara JE; Agronin M; Davis CS; Nguyen U; Shin P; Tariot PN; Siffert J
    JAMA; 2015 Sep 22-29; 314(12):1242-54. PubMed ID: 26393847
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A review of anticonvulsants in treating agitated demented elderly patients.
    Grossman F
    Pharmacotherapy; 1998; 18(3):600-6. PubMed ID: 9620110
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Quetiapine treatment of psychosis associated with dementia: a double-blind, randomized, placebo-controlled clinical trial.
    Tariot PN; Schneider L; Katz IR; Mintzer JE; Street J; Copenhaver M; Williams-Hughes C
    Am J Geriatr Psychiatry; 2006 Sep; 14(9):767-76. PubMed ID: 16905684
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Valproic acid in dementia: does an optimal dose exist?
    Dolder CR; Nealy KL; McKinsey J
    J Pharm Pract; 2012 Apr; 25(2):142-50. PubMed ID: 22095580
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Extended-release divalproex sodium for mood stabilization.
    Stoner SC; Dubisar BM; Lea JW; Marken PA; Ramlatchman LV; Reynolds JB
    Pharmacotherapy; 2004 Sep; 24(9):1147-53. PubMed ID: 15460175
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Quetiapine for agitation or psychosis in patients with dementia and parkinsonism.
    Kurlan R; Cummings J; Raman R; Thal L;
    Neurology; 2007 Apr; 68(17):1356-63. PubMed ID: 17452579
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Carbamazepine treatment of agitation in nursing home patients with dementia: a preliminary study.
    Tariot PN; Erb R; Leibovici A; Podgorski CA; Cox C; Asnis J; Kolassa J; Irvine C
    J Am Geriatr Soc; 1994 Nov; 42(11):1160-6. PubMed ID: 7963202
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A randomized, double-blind, placebo-controlled tolerability study of intramuscular aripiprazole in acutely agitated patients with Alzheimer's, vascular, or mixed dementia.
    Rappaport SA; Marcus RN; Manos G; McQuade RD; Oren DA
    J Am Med Dir Assoc; 2009 Jan; 10(1):21-7. PubMed ID: 19111849
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Aripiprazole for the treatment of psychoses in institutionalized patients with Alzheimer dementia: a multicenter, randomized, double-blind, placebo-controlled assessment of three fixed doses.
    Mintzer JE; Tune LE; Breder CD; Swanink R; Marcus RN; McQuade RD; Forbes A
    Am J Geriatr Psychiatry; 2007 Nov; 15(11):918-31. PubMed ID: 17974864
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Tetrahydrocannabinol for neuropsychiatric symptoms in dementia: A randomized controlled trial.
    van den Elsen GA; Ahmed AI; Verkes RJ; Kramers C; Feuth T; Rosenberg PB; van der Marck MA; Olde Rikkert MG
    Neurology; 2015 Jun; 84(23):2338-46. PubMed ID: 25972490
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The effect of risperidone on nursing burden associated with caring for patients with dementia.
    Frank L; Kleinman L; Ciesla G; Rupnow MF; Brodaty H
    J Am Geriatr Soc; 2004 Sep; 52(9):1449-55. PubMed ID: 15341545
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Safety and effectiveness of divalproex sodium extended release containing regimen in Indian patients with bipolar I disorder in continuation phase: Results of EASED registry.
    Shah N; Reddy MS; Vohra S; Chaudhuri U; Mohanasundaram S
    Asian J Psychiatr; 2016 Apr; 20():32-8. PubMed ID: 27025469
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effects of sodium valproate on behavioral disturbances in elderly outpatients with dementia.
    Mizukami K; Hatanaka K; Ishii T; Iwakiri M; Sodeyama N; Tanaka Y; Asada T
    Geriatr Gerontol Int; 2010 Oct; 10(4):324-6. PubMed ID: 20887626
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.